IL17A and metabolic syndrome: Inflammation and dyslipidemia were mild determinants in the adjusted model: interleukin-6 (IL-6)(β = 0.274, p = 0.0003), interleukin-17 (IL-17) (β = 0.009; p = 0.004), tumor necrosis factor-alpha (TNF-α)(β = 0.337, p = 0.001), monocyte chemoattractant protein-1 (MCP-1)(β = 0.003; p = 0.005), fasting TG (β = 0.007; p = 0.006) and leptin (β = 0.041; p = 0.009).